Home/ Supplements/ Melatonin/ COR-Performance ZMA

COR-Performance ZMA

product on market Capsule Cellucor Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 25% of ingredients have research evidence
B Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

ZMA and melatonin are supported by moderate evidence for improving sleep quality and recovery. Tribulus terrestris and GABA have limited research supporting their efficacy for performance or hormonal enhancement in healthy adults. Overall, the evidence coverage for this specific ingredient profile is very low.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for COR-Performance ZMA
Open Full PDF View on NIH DSLD →
Details

Label Data

4 Capsule(s)
Serving Size
30
Servings
Other Combinations
Product Type
25%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

ZMA
2400 mg
Tribulus terrestris extract
750 mg
GABA
50 mg
1 mg
Market median: 3.0mg (984 products) 240 studies (A:2, B:109)

Other Ingredients

Millet Flour Silicon Dioxide Magnesium Stearate Vegetable Gelatin
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

SUGGESTED USE: Take one serving (four capsules) COR-Performance(TM) ZMA(R) per day, 30-60 minutes before bedtime. For best results, avoid taking with dairy or other calcium-containing foods or supplements.

Warnings & Precautions

WARNING: This product is only intended for use by healthy adult men, 18 years of age or older.

This product is not for use by women, particularly those who are pregnant or nursing.

Do not use this product if you have a serious medical condition.

Consult your physician or health care professional before using this product, if you have or suspect you have any medical condition including but not limited to an auto-immune condition, a depressive disorder, a sleep condition, high or low blood pressure or diabetes.

Do not take this product if you are currently taking any prescription or over-the-counter medication including sedatives or other CNS depressants, corticosteroids, immunosuppressants, anti-coagulants or medications to treat diabetes or high or low blood pressure.

Do not take this product in combination with alcoholic beverages. This product contains ingredients which may cause drowsiness. Do not operate a vehicle or heavy machinery following consumption of this product. Discontinue use and call a health care professional immediately if you experience any adverse reaction to taking this product. Follow label instructions and do not exceed recommendations for Suggested Use.

KEEP OUT OF REACH OF CHILDREN

Formulation Notes

2400mg ZMA(R) 750mg Tribulus Terrestris 50mg GABA PER DAILY SERVING

Additional Information

MANUFACTURED IN A GMP CERTIFIED FACILITY

{check} INFORMED CHOICE WWW.INFORMED-CHOICE.ORG

TruFacts(TM) FULL DISCLOSURE LABEL

v1.0

GLUTEN FREE

COR-PERFORMANCE SERIES

Woodbolt(TM) INTERNATIONAL

Metadata

Product Details

UPC / SKU6 32964 30430 8
DSLD Entry Date2013-03-25
Product TypeOther Combinations
FormCapsule
DSLD ID18932
Data Updated2026-04-11
Research

Research Evidence

291
Research Sources
55
Avg Quality
129
Meta Analysis
93
Systematic Review
51
Rct
11
Clinical Trial
2
Other
2
Regulatory Source
1
Openfda Safety
A Interventions for preventing delirium in hospitalised non-ICU patients
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Melatonin for preoperative and postoperative anxiety in adults
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Effect of melatonin on quality of life and symptoms in patients with cancer: a systematic review and meta-analysis of randomised controlled trials
Meta Analysis BMJ open 2022 PubMed DOI
B Pharmacological interventions for prevention of weight gain in people with schizophrenia
Meta Analysis The Cochrane database of systematic reviews 2022 PubMed DOI
B Melatonin for pre- and postoperative anxiety in adults
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
B Prevention of depression in adults with long-term physical conditions
Meta Analysis The Cochrane database of systematic reviews 2021 PubMed DOI
B Comparative effects of pharmacological interventions for the acute and long-term management of insomnia disorder in adults: a systematic review and network meta-analysis
Systematic Review Lancet (London, England) 2022 PubMed DOI
B Does melatonin administration reduce the incidence of postoperative delirium in adults? Systematic review and meta-analysis
Meta Analysis BMJ open 2023 PubMed DOI
B Second-generation antidepressants for preventing seasonal affective disorder in adults
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
B Interventions for preventing type 2 diabetes in adults with mental disorders in low- and middle-income countries
Meta Analysis The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Melatonin →
Compare

Similar Products

View all Melatonin products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.